美的醫療與巴西VMI集團簽署戰略合作協議
5月12日,在中巴兩國政府代表見證下,中國美的醫療旗下萬東醫療與巴西VMI集團今日正式簽署戰略合作備忘錄。巴西總統盧拉、總統府首席部長、衛生部長等出席簽約儀式。

根據協議內容,雙方將在巴西成立合資公司,重點開展MRI、CT及Cath lab等高端醫療裝備的研發與本土化生產。合資企業將設立生產設施與研發中心,推動醫療技術適應當地市場需求,並共同開拓拉美市場。
據瞭解,萬東醫療作爲中國醫療設備製造領軍企業,與VMI集團已有15年合作歷史。雙方共同合作的超導磁共振已在巴西市場實現安裝與銷售。VMI集團是巴西本土知名醫療影像設備製造商,擁有35年行業經驗和本地化服務網絡。

盧拉總統在簽約儀式上表示,這一合作是中巴經貿合作的重要成果,將進一步提升巴西高端醫療設備製造能力,促進當地醫療水平提升。中方代表指出,將積極推動合作項目落地見效,爲深化中巴醫療衛生領域合作作出新貢獻。
近年來,中巴兩國在醫療衛生領域合作不斷深化。此次合作標誌着兩國醫療產業合作邁出新步伐,將爲共建"健康絲綢之路"注入新動力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.